Similar articles

• Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial.

  Martínez-González MA, Buil-Cosiales P, Corella D, Bulló M, Fitó M, Vioque J, Romaguera D, Martínez JA, Wärnberg J, López-Miranda J, Estruch R, Bueno-Cavanillas A, Arós F, Tur JA, Tinahones F, Serra-Majem L, Martín V, Lapetra J, Vázquez C, Pintó X, Vidal J, Daimiel L, Delgado-Rodríguez M, Matía P, Ros E, Fernández-Aranda F, Botella C, Portillo MP, Lamuela-Raventós RM, Marcos A, Sáez G, Gómez-Gracia E, Ruiz-Canela M, Toledo E, Alvarez-Alvarez I, Díez-Espino J, Sorlí JV, Basora J, Castañer O, Schröder H, Navarrete-Muñoz EM, Zulet MA, García-Rios A, Salas-Salvadó J; PREDIMED-Plus Study Investigators. Martínez-González MA, et al. Int J Epidemiol. 2019 Apr 1;48(2):387-388o. doi: 10.1093/ije/dyy225. Int J Epidemiol. 2019. PMID: 30476123 No abstract available.
• Cohort profile: the electricity generating authority of Thailand study.

  Vathesatogkit P, Woodward M, Tanomsup S, Ratanachaiwong W, Vanavanan S, Yamwong S, Sritara P. Vathesatogkit P, et al. Int J Epidemiol. 2012 Apr;41(2):359-65. doi: 10.1093/ije/dyq218. Epub 2011 Jan 6. Int J Epidemiol. 2012. PMID: 21216741 No abstract available.
• The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.

  Kones R. Kones R. Ther Adv Cardiovasc Dis. 2009 Aug;3(4):309-15. doi: 10.1177/1753944709337056. Epub 2009 May 21. Ther Adv Cardiovasc Dis. 2009. PMID: 19460829 Review.
• Adherence to a Mediterranean-type diet and reduced prevalence of clustered cardiovascular risk factors in a cohort of 3,204 high-risk patients.

  Sánchez-Taínta A, Estruch R, Bulló M, Corella D, Gómez-Gracia E, Fiol M, Algorta J, Covas MI, Lapetra J, Zazpe I, Ruiz-Gutiérrez V, Ros E, Martínez-González MA; PREDIMED group. Sánchez-Taínta A, et al. Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):589-93. doi: 10.1097/HJR.0b013e328308ba61. Eur J Cardiovasc Prev Rehabil. 2008. PMID: 18830087 Clinical Trial.
• Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.

  Ridker PM; JUPITER Study Group. Ridker PM, et al. Circulation. 2003 Nov 11;108(19):2292-7. doi: 10.1161/01.CIR.0000100688.17280.E6. Circulation. 2003. PMID: 14609996 Review. No abstract available.